Compare ALKS & PFSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ALKS | PFSI |
|---|---|---|
| Founded | 1987 | 2008 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.7B | 3.7B |
| IPO Year | 2012 | 2018 |
| Metric | ALKS | PFSI |
|---|---|---|
| Price | $40.84 | $62.44 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 19 | 8 |
| Target Price | $56.56 | ★ $90.57 |
| AVG Volume (30 Days) | ★ 1.7M | 453.6K |
| Earning Date | 10-27-2026 | 10-20-2026 |
| Dividend Yield | N/A | ★ 1.94% |
| EPS Growth | N/A | ★ 59.25 |
| EPS | N/A | ★ 1.94 |
| Revenue | ★ $1,475,899,000.00 | $984,629,000.00 |
| Revenue This Year | $23.57 | N/A |
| Revenue Next Year | $6.48 | $25.92 |
| P/E Ratio | ★ N/A | $32.82 |
| Revenue Growth | N/A | ★ 3.05 |
| 52 Week Low | $27.00 | $63.03 |
| 52 Week High | $55.67 | $160.36 |
| Indicator | ALKS | PFSI |
|---|---|---|
| Relative Strength Index (RSI) | 31.74 | 22.34 |
| Support Level | $36.25 | N/A |
| Resistance Level | $51.25 | $87.46 |
| Average True Range (ATR) | 1.42 | 1.59 |
| MACD | -0.27 | -0.27 |
| Stochastic Oscillator | 15.22 | 3.79 |
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.
PennyMac Financial Services Inc is a specialty financial services firm with a comprehensive mortgage platform mainly focused on the production and servicing of U.S. residential mortgage loans. The firm is also engaged in managing investments related to the U.S. mortgage market and provides products and services that leverage technologies to support customers. The company operates through two reportable operating segments: production and servicing. The production segment performs loan origination, acquisition, and sale activities, while the servicing segment performs servicing and subservicing of loans, early buyout transactions, and servicing of loans sourced and managed for PMT. The majority of revenue comes from the production segment.